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Abstract
Multidisciplinary team (MDT) approach has been shown to reduce diabetic foot ulcerations (DFUs) and lower
extremity amputations (LEAs), but there is heterogeneity between team members and interventions.
Podiatrists have been suggested as“gatekeepers”for the prevention and management of DFUs. The purpose
of our study is to review the efect of podiatric interventions in MDTs on DFUs and LEAs. We conducted a
systematic review of available literature. Data’s heterogeneity about DFU outcomes made it impossible for us
to include it in a meta-analysis, but we identified 12 studies fulfiling inclusion criteria that alowed for them
to be included for LEA outcomes. With the exception of one study, al reported favourable outcomes for
MDTs that include podiatry. We found statistical significance in favour of an MDT approach including
podiatrists for our primary outcome (total LEAs (RR: 0.69, 95% CI 0.54–0.89, I2=64%,P= 0.002) and major
LEAs (RR: 0.45, 95% CI 0.23–0.90, I2=67%,P< 0.02). Our systematic review, with a standard search strategy, is
the first to specificaly address the relevant role of podiatrists and their interventions in an MDT approach for
DFU management. Our observations support the literature that MDTs including podiatrists have a positive
efect on patient outcomes but there is insuficient evidence that MDTs with podiatry management can
reduce the risk of LEAs. Our study highlights the necessity for intervention descriptions and role definition in
team approach in daily practice and in published literature.
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Introduction
Diabetes is a worldwide health issue and of its many
complications, diabetic foot ulceration (DFU) is a
prominent problem [1]. Up to 25% of people with
diabetes wil experience a DFU in their lifetime, and
about 85% of lower limb amputations are preceded by
aDFU[2,3]. The 5-year mortality rate exceeds 70%
with a lower-extremity amputation (LEA) [4,5].
Consequently, DFUsindiabetespatientsshouldbe
perceived as a major warning sign for morbidity and
mortality, and as such, they require close monitoring,
medical folow-up, and integrated foot care [6,7].
Integrated foot care is a pathway of care management
with rapid and appropriate access to a multidisciplin-
ary team (MDT) for coordinated care between hos-
pital and community services [8]. An MDT in which
health professionals work together to achieve the best
outcomes for patients with an at-risk diabetic foot
has been developed in response to the need for
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improved methods of service delivery. A number of
health disciplines can be involved such as medicine
(general medicine, endocrinology, infectious diseases
medicine, and vascular, plastic and orthopaedic sur-
geries), podiatry, nursing, nutrition, orthotics and
prosthetics, physiotherapy,and psychology. Each disci-
pline’s implication in the MDT depends on the stage
of the DFU, but podiatry has a central role through-
out [9–11]. The first foot care MDTs were established
in the United Kingdom in the late 1980s and
highlighted the role of chiropody (former designation
for podiatry).
Previous systematic reviews have linked MDTs to
lower LEA rates folowing a DFU, noting the high
heterogeneity of MDTs composition and interventions
[12–15]. Neither of these reviews, however, looked
specificaly at a specific member and its interventions.
International guidelines recommend at least 3 levels
of foot care management based on foot risk, and po-
diatrists are included at each level [16]. Many studies
about multidisciplinary healthcare centres in Europe
and in the United States reported that this approach
helped reduce amputation rates by 36 to 86% [17,
18]. However, the structures and delivery of these
MDTs vary across settings and countries [19–22]. As
part of an MDT approach, podiatrists have been sug-
gested to serve as“gatekeepers”for the prevention
and management of diabetes-related foot complica-
tions [11,23]. Podiatric management of an at-risk
diabetic foot has an underlying focus on preventive
screening, education, ofloading, and foot care [2]. It
is usualy assumed that podiatry prevents LEA; how-
ever there is insuficient evidence to demonstrate the
efect of patient contact with a podiatrist in a system-
atic review and meta-analysis [24]. So far, the efects
of MDTs including podiatry and its interventions
have not been demonstrated [12,13,24]. The part-
nership with podiatrists for DFU management in
MDTs is a logical one, and the expertise and skils of
each team member can improve outcomes and limb
salvage [25]. It is wel known that podiatry is limited
and is a variable resource (in terms of accessibility, fi-
nancial coverage and scope of practice) in several
healthcare systems. In that context, it is sensible to
question whether or the podiatrist is a resource that
makes a diference for patient outcomes. There is
therefore a need to look for the efectiveness of
MDTs which specificaly include contact with podiatry
(from diferent scope of practice around the world)
on DFUs and LEAs in people with diabetes. The ob-
jective of this study is to examine the efect of pa-
tients’contact with podiatry in MDTs and highlight
its specific role and, if possible, determine which po-
diatric interventions play a key role in MDTs.
Method
exclusion criteria/exclusion criteria
The research question was“What is the efect of con-
tact with a podiatrist and their interventions in an
MDT context, on LEAs and DFUs, in individuals with
diabetes?”[26]. Results for the efect of podiatric in-
terventions without an MDT with a similar methodo-
logical approach wil be presented in a diferent
article. Inclusion criteria were studies that included
participants 18 years of age or older and having a
diagnosis of either type 1 or 2 diabetes. There were
no restrictions regarding the date of publication, geo-
graphical location, or study seting. Randomised con-
troled trials (RCTs), cohorts, either prospective or
retrospective, and comparative cohorts before and
after for which a reported efect on LEAs or on DFUs
was available were included. The targeted interven-
tions (presented in Table1) were educational preven-
tion, foot cares, ofloading, infection control, wound
cares and surgical strategiesthat had to be specificaly
delivered by a podiatrist in a multidisciplinary context
or in an MDT program. The participation of the po-
diatrist had to be clearly identified in the article. To
be included, articles had to use a comparison group
including interventions or treatments without an
MDT context. Potential measured outcomes that were
deemed relevant for this study are presented in
Table2. The exclusion criteria for the articles were:




Examples of podiatric interventions
Preventive strategies - Stratification of the population risk
- Program for vulnerable populations
- Pedorthic evaluation
Educational strategies - Program for self-management and
support for self-management
- Personal hygiene education
Foot cares strategies - Calus management
- Nail management
Ofloading strategies - Orthoses
- Management with shoes
- Walking aids
- Immobilisation
Infection control and wound
care strategies
- Specialised wound dressing
- Infection algorithm
- Biofilm-based wound care
- Advanced adjuvant therapies such as
hyperbaric oxygen therapy, negative
pressure therapy, etc.
Surgical strategies - Surgical debridement
- Corection of bone deformities
- Tissue engineering and grafts
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French and English, and type of publications such as
case-control studies, cross-sectional studies, audit, re-
view articles, charts reviews, cases series, and case
studies, as wel as conference and communication pa-
pers. Finaly, a predefined review protocol was regis-
tered at the PROSPERO international prospective
register of systematic reviews, registration number
CRD42017057851 [28].
Search strategy
CENTRAL, CINAHL, EMBASE and MEDLINE data-
bases were searched to identify relevant studies pub-
lished up to February 1, 2020. The strategy was adapted
as per database requirements, and we combined the re-
sults from the diferent databases and are available in
Additional file1. We also searched for other potential
publications identified through search strategy from grey
literature and references cited in relevant articles [29].
Data colection, extraction and management
Two review authors (VB and MBF) independently
assessed the titles and abstracts of al studies obtained
from the databases, and ful copies of the articles that
met the inclusion criteria were consulted for the next
step. In case of disagreement or doubt between the two
authors, a decision was obtained by consensus folowing
a discussion between reviewers (VB and MBF). If a
consensus could not be reached, a third reviewer was
consulted (LC). Folowing the selection, the Cohen’s
kappa was calculated to measure the agreement between
the two independent authors.
Data from included articles was extracted and re-
corded independently by two review authors (VB and
MBF) using a standardised extraction sheet adapted
for the data of this review [26]. Data sheets were
compared and discrepancies were discussed between
the two investigators (VB and MBF). Risk of foot dis-
ease at baseline was assessed using the Diabetic foot
risk stratification and triage system from the SIGN
(Scottish Intercolegiate Guidelines Network) system
guidelines because this system showed higher diagnos-
tic accuracy values [30,31]. If the data required was
missing from the published article, we tried to reach
the authors.
Assessment of risk of bias in included studies
Assessment of risk of bias was dependent on each
study’s design. For cohort and pre and post cohorts,The
Joanna Briggs Institute Critical Appraisal Tools for Sys-
tematic Reviewswere performed through a qualitative
evaluation checklist specificaly elaborated for these de-
signs [32]. Results are expressed by the frequency of
each classification. Risk of bias assessment was per-
formed for within and across studies independently by
the two authors (VB and MBF). A third reviewer (LC)
was involved to resolve disagreements. Excel (Microsoft
Corporation, Redmond, WA, USA) was used to repre-
sent the potential risk of bias.
Measures of treatment efects and synthesis
When appropriate, meta-analysis was performed in
order to pool outcome data with Review Manager ver-
sion 5.3 (RevMan, The Cochrane Colaboration, Oxford,
United Kingdom) for statistical analysis for suitable stud-
ies [33]. We also assessed the heterogeneity by using the
Cochrane’s Q statistic (I2index). Quantitative synthesis
using the Mantel-Haenszel method with fixed efect
models (I2index inferior or equal to 50%) or random ef-
fect models (I2index between 50 and 75%) were used.
We considered an I2index greater than 75% indicative
of substantial statistical heterogeneity [34]. In such cases,
a qualitative analysis and narrative synthesis were pro-
duced. Risk ratios (RR) were chosen for reporting the
pooled efect of dichotomous data with a confidence
interval (CI) of 95%. Generic efect of inverse variance
model was used when studies reported association mea-
sures. Statistical significance was set atp< 0.05. To as-
sess publication bias, a funnel plot of the overal
estimate of a primary outcome and its standard error
(SE) was performed.
Table 2List of potential outcomes measured
Outcomes






























•Length of hospital stay
•Cost-efectiveness
Patient satisfaction
Bold characters: Outcomes included in meta-analysis
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Subgroup analysis
We decided to analyse whether the role of podiatrists in
the MDT with regard to their implication in the team
was primary (leading role or core of the team), second-
ary (support to the MDT but not the leading role), or
tertiary (external consultation when needed). We also
conducted diferent subgroup analyses based on our pre-
determined outcomes such as risk stratification of the
population, healthcare seting, quality of studies, comor-




From 4987 titles retrieved from the databases, 2 from grey
literature, and another 10 from reference lists of potential
included studies (see Additional file3), 476 articles were
reviewed for titles and abstract after removing duplicates.
Folowing this selection, the Cohen’s kappa was calculated
between the two independent authors (VB and MBF) and
was of 0.96, indicating excelent agreement between both
reviewers. We then identified 26 articles that met the eligi-
bility criteria (10 cohorts, 16 comparative pre and post co-
horts, and 0 RCTs). None of studies from the grey
literature or reference lists were included. A PRISMA
flow diagram with motives for exclusion of 178 studies is
represented in Fig.1, and details of excluded studies are in
Additional file4. Twenty-six studies that reported out-
comes for podiatric interventions in an MDT context
were included in this systematic review. Of these, 3 sets of
articles were from the same group of authors, [35–38]and
[39,40]. The decision was made to exclude the oldest
ones, based on the fact that the same data set was used.
Therefore, 23 studies were included in this systematic
Fig. 1PRIMA flow diagram
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review and only 12 for the meta-analysis, considering that
11 studies did not meet the eligibility criteria after ful-text
reading and analysis. One included cohort study had 4
substudies [41] and another, 2 substudies [38]. Reasons
for exclusion (consensus between authors) were: mixed
data when reporting primary outcome [42], eminent dif-
ference of basic population [43–45], podiatric interven-
tions pre and post cohort [46] and incomplete data for
pooling the outcomes [40,47–51].
Description of included articles
Characteristics of the studies included for meta-analysis
(n= 12), such as study design and information concern-
ing length of folow-up, seting, source of data, partici-
pants, interventions and description of the MDT,
comparison, outcomes, and risk stratification are pre-
sented in Additional file5. Al 23 studies included in the
systematic review were in English. We identified 6 stud-
ies from the United States [40,45,47,48,54,55], 2 from
Canada [44,55] and 10 from Europe, of which 5 were
from the United Kingdom [41,43,50,56,57], 2 from
Spain [36,38], 1 from Sweden [51], 1 from the
Netherlands [58] and 1 from Italy [49]. There were also
3 articles from Asia, of which 2 were from China [42,
59] and 1 from Singapore [60]. One publication was re-
spectively from Australia [61] and another from New
Zealand [46]. Publication years were from 1990 to 2019.
Four articles were published before 2000 [50–52,57],
and 3 articles were from 2000 to 2009 [38,43,49], while
the majority (16 articles) was published between 2010
and 2019 [36,40–42,45–47,54–56,58,60–63]. Lengths
of folow-ups were between 1 and 14 years, with a me-
dian of 3.8 years and a mean of 3.6 years. Study setings
were mostly in tertiary care [36,38,40,43–47,50,54,
55,57–59,61]. There were 4 studies based in primary
care [42,48,49,63], 3 in secondary care setings [51,56,
60] and 1 unknown [41]. Three articles colected pro-
spective data [38,50,57]; al other analyses were carried
out using retrospective data (electronic medical records,
medical charts, databases with coding). The 12 articles
which were combined for meta-analysis accounted for
545,829 patients. The participants’characteristics at
baseline were heterogeneous. According to our stratifica-
tion system of choice for the population (SIGN) [30], 21
studies had a population stratification categorised as
high risk. This is explained by the fact that the popula-
tion included in the studies could either have a DFU or
a history of DFU [45,47,50,55,57,58,60,61], an am-
putation or a history of amputation [36,40,43–45,48,
51,61], peripheral vascular disease (PVD) [45,56], or
diabetic foot infection [52,61,62]. Stratification of the
population with PVD, neuropathy, celulitis, osteomye-
litis or Charcot foot is also categorized as a moderate to
high-risk population [41]. Four articles included both
categories (high and low risk) [38,42,49,54] and 4 arti-
cles had a system of classification of their population or
DFUs: surgery classification [47], LEAs risk with King’s
classification [60], Wagner’s classification for ulcers [59],
and Texas University classification for DFUs [54].
The specific podiatric interventions were al poorly de-
scribed (without information concerning nature, inten-
sity, duration, frequency) and very heterogeneous. In the
12 included studies, podiatric interventions are stated as
contact with podiatry [36,40–42,45,49,51,55,58,59,
61,63]. Thus, we classified the podiatric interventions as
educational strategies [38,43,50,54,57,60], foot care
strategies [38,43,46,50,54,56,57,60], ofloading strat-
egies [43,46,48,55–57], wound care and infection con-
trol strategies [44,48,54], surgical strategies [44,47,54],
and stratification [38,42,49]. Only a few studies had de-
fined exposure to the interventions as a weekly exposure
to podiatry [56,60], a regular folow-up in podiatry or
monthly appointments [38,43,50] or at least every 3
months [57]. Concerning the role of the podiatrist, we
decided a posteriori to distinguish their role according
to their implication in the MDT. With this in mind, the
podiatrist intervenes in a primary role in 8 articles (lead-
ing role or core of the team) [36,43,44,47,48,54,55,
59]. Specificaly, in these articles, the podiatrist formed
the core of the team with endocrinologists [36,59],
nurses [43,55], and vascular surgeons [44,47,54]. Podi-
atrists are sole leaders in one article [48]. In 8 articles,
they had a secondary role (support to the MDT but
without a leading role) [45,46,49,51,56,58,60,61]
and in 2 articles, they had a tertiary role (external con-
sultation when needed) [38,42]. Podiatrists’role was
similar to other team members in two articles [50,57].
Finaly, in 3 articles, it was impossible to determine the
level of the podiatrist’s implication in the MDT because
no description of the team was provided. In one article
[52], it was a podiatry-established critical pathway and in
the two others, it was with other lower-extremity spe-
cialists [40,41]. The MDTs composition was also vari-
able; some MDTs showed care management in 2 levels
of team members’implication [36,42,47,49]. Finaly,
funding and conflict of interest in the included articles
were clearly mentioned in the ful text of 14 out of 23
articles [36,41–44,47,48,51,54,55,57,60–62].
Primary outcomes
Al the studies included in the meta-analysis (n= 12) re-
ported favourable data for people with diabetes in an
MDT management that included podiatry. Therefore,
we retrieved data related to our pre-defined outcomes
about DFUs and LEAs as stated in Table1. Al included
articles had data concerning primary outcomes: LEAs
[36,38,41,54–58,60,62,65] and DFUs [38,54,55,57,
58]. With regard to the 11 studies excluded for the
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meta-analysis, but included in the systematic review
(n= 23), 10 out of 11 studies reported data in favour of
MDTs including podiatry [40,42,44–47,49–51,53] and
one article reported no efect of the interventions [43].
That led us to conduct two separate meta-analyses based
on study design (see Fig.1). Main results are shown in
Fig. 2from available data pooled together, which
respects criteria of heterogeneity. For total LEAs as
the primary outcome, the random efect model was
applied and a significant result was found in favour of
MDTs with podiatry (RR: 0.69, 95% CI 0.54–0.89,
I2= 64%,P= 0.002). For major LEAs (level defined as
above knee amputation and/or below knee amputa-
tion), results were also in favour of MDTs with
podiatry and stil significant (RR: 0.45, 95% CI 0.23–
0.90, I2= 67%,P< 0.02). The result was not significant
for minor LEAs (level defined as amputations at any
level of the foot) (RR: 0.93, 95% CI 0.59–1.40, I2=
55%,P= 0.76). We succeeded in pooling results from
2 pre and post cohorts’with cohort study analysis,
which increased the number of studies included to 8
for meta-analysis. Raw data from these 2 studies
Fig. 2Forest plot for cohort studiesa) Total LEAsb) Major LEAsc) Minor LEAs
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alowed us to calculate the prevalence of LEAs per
year per period pre-and post-intervention from a
sample size based on government census data in the
area. Therefore, events of LEAs from exposed group
to MDTs and non-exposed group to MDTs were cal-
culated [36,56]. For the remaining pre and post co-
hort (n=4) [55,58–60], because of the significant
heterogeneity between studies, we decided not to pool
the data with association measure. Pre and post co-
hort MDTs have reported significant results in favour
of MDTs to improve DFU healing rate [55,58]and
reduce total LEA [58,59] and major LEA [58–60].
Visual inspection of the funnel plot for the included
cohort studies for total LEAs has demonstrated no
strong evidence of publication bias of the studies in
favour of the interventions (Fig.3). The heterogeneity
in DFU data has not alowed meta-analysis for cohort
studies.
Secondary outcomes
According to our predefined secondary outcomes (Table1),
data was available for mortality/survival [36,41,43,54,58],
recurrence [43,54,57], other complications [54,61,64], and
healthcare data [49,54,56,57,59,61,63,64]. Meta-analyses
were performed for some studies, but heterogeneity was over
75%. No articles reported data concerning patients’satisfac-
tion with care provided by MDTs.
Risk of bias assessment of included studies
In relation to the critical appraisal of quality and experi-
mental designs, bias analyses for cohorts have shown
that none of the included studies fulfiled al parameters
for low risk of bias, but the majority of the studies in-
cluded (4/6) had a low risk of bias for the folowing pa-
rameters: population, confounders identified, outcomes
measured, folow-up time, and appropriate statistical
analysis. High risk of bias was present concerning the
baseline population (those who were not free of LEAs or
DFUs at the beginning of the study) and the exposure
(valid and reliable method to measure MDTs contact
and intervention) (see Fig.4a). Bias analysis for pre and
post cohorts have also shown the same trend of high risk
of bias in included studies. None of the included studies
fulfiled al parameters for low risk of bias, but the ma-
jority of the studies included (4/6) had a low risk of bias
for 2 parameters: outcome measurements and appropri-
ate statistical analysis. In almost al studies, there is con-
fusion about the cause and efect variables (5/6) and
diference about folow-up time between pre and post
cohorts (4/6). Exposition to intervention was a low risk
of bias for only 2 study out of 6. Few studies had a con-
trol group (2/6) (see Fig.4b).
Discussion
A rigorous systematic search of the literature led to the
inclusion of 8 studies in a meta-analysis performed to
answer our research question. This was alowed because
the heterogeneity of included studies, depending on the
outcomes, was lower than 75% and the Chi-square test
result was less than 30% with significantp-value (IC
90%) [33]. The ultimate aim in diabetic foot care is to
avoid DFUs and resulting LEAs for individuals with
diabetes. The goals and benefits from an MDT that in-
cludes a podiatrist reside in complementary work and
Fig. 3Funnel plot of cohort included studies for total LEAs
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synergy of skils and knowledge to achieve best out-
comes for the patients [65]. This was addressed in al in-
cluded studies on MDTs that included podiatry.
However, even though our study has looked closely at
diferent podiatric interventions in an MDT, there is not
enough reported information and descriptions of inter-
ventions to examine specific podiatric interventions’efi-
ciency. Despite this, from the information available,
interventions were mainly educational strategies and foot
care strategies. It becomes problematic to distinguish
precisely whether it is the intervention as performed
specificaly by a podiatrist that is efective or if it is the
intervention itself. According to the interventions de-
scribed in the included studies, podiatric interventions
could have been done by other team members (for ex-
ample, by a nurse). The evidence of value added by podi-
atrists in an MDT remained weak in that context. It
would have been relevant to have a description of inter-
ventions requiring specific podiatrist skils and know-
ledge in the MDT such as foot surgeries and ofloading,
which are interventions highly recommended in
guidelines for DFU management and very specific to the
podiatry competency framework [28]. Only one study in-
tegrated specific competencies in their MDT manage-
ment [47]. For these reasons, we have analysed the
relative efect of contact with MDTs that include podiat-
ric interventions as a relative reduction of risk.
Clinical significance
The results of this systematic review support the concept
that MDTs with podiatrists lead to a statisticaly signifi-
cant reduction of LEAs (total and major LEAs) com-
pared to interventions without MDTs. After qualitative
analysis, authors of the included studies examining
minor LEAs as outcomes (al except [38,61]) have
shown that there are more minor LEAs with MDT inter-
ventions. However, upon analysis of results in relation
with other severities of LEAs (major versus minor) and
with total LEAs, level of LEAs may decrease with an
MDT with podiatry management. There is a 31% relative
risk reduction in undergoing a LEA, either major or
minor, with MDT management with podiatry for people
Fig. 4Potential risk of bias with JBI toolsa) Cohort studiesb) Pre and post cohort studies
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at risk for diabetic foot. Considering only major LEAs,
the relative risk reduction was of 55%. These results are
clinicaly meaningful in favour of the intervention, con-
sidering the high 5-year mortality rate and the low qual-
ity of life of patients with diabetes who undergo LEAs
[4,5]. Even if these results are consistent with the
current literature, this should be interpreted with cau-
tion. Hence, this review cannot make any new recom-
mendations about practice due to several
methodological flaws discovered during quality appraisal
of the included studies.
Literature comparison and findings
Three Cochrane reviews of interventions that evaluated
the outcomes of LEAs or DFUs in patients with diabetes
concluded that there is insuficient evidence that com-
plex interventions and educational interventions can re-
duce the risk of LEA or DFUs [66–68]. A fourth review,
from the International Working Group on the Diabetic
Foot, concluded that integrated foot care in MDTs can
prevent DFUs in at-risk patients [69]. These authors also
mentioned substantial heterogeneity between articles
concerning the description of team members, interven-
tions, and design. Previous reviews did not atempt to
single out one member in particular, contrary to this
systematic review which focuses on podiatry, but have
suggested focusing on similarities of team makeups to
help determine the real impact [12,13]. In general, these
studies highlighted the complexity of comparing the re-
sults of team work from one study to another to draw
conclusions, particularly with teams which did not have
the exact same set of skils and organization. Research of
true efect size with the specific criterion of contact with
podiatry, could have helped to assess the colective efort
in MDTs. A common conclusion from al of these previ-
ous publications was that high-quality evidence from in-
cluded studies is lacking. Our findings are also coherent
with other reviews about the efectiveness of MDTs in
reducing major LEA [14,15].
Studies included in this systematic review were very
heterogeneous, as it was concluded in previous system-
atic reviews. Confounders and risk factors for LEAs and
DFUs are wel known in people with diabetes [70,71].
Few studies presented a strategy of risk classification in
management (5/12) that alowed us to split the cohort
according to the risk [38,41], but it was not possible for
the other articles [54,59,60]. Even with the eforts of
stratification of the risk for the population at baseline
(low risk to active DFUs) across the studies to pool the
results, the characteristics of the included populations
were sometimes not specified [36,41,42,48]. The base-
line population can also lead to poor prognoses, inde-
pendently of the interventions. Such was the case for
patients presenting with infections, gangrene, necrosis,
PVD, and Charcot neuroarthropathy at baseline [52,56,
59,61,63,64,72]. These intrinsic variations of the
population within a study are a factor that explains het-
erogeneity of the results and the gap with the true efect
size.
Limitations and strengths
To the best of our knowledge, this is the first systematic
review that investigates contact with podiatry in an
MDT context on the occurrence of LEAs in individuals
with diabetes. It was also a first atempt to describe po-
diatric interventions specificaly in MDTs. This had been
suggested for further work from a previous meta-
analysis [24]. The strengths of this systematic review are
the rigorous search strategies, including an atempt to
address the risk of bias. The relevance of the findings to
clinical practice is coherent with the recommendations
of diferent diabetes associations and organisations
which support MDT management of DFUs, such as the
American Diabetes Association, the Canadian Diabetes
Association, and the International Working Group on
the Diabetic Foot, to name only a few examples. Al-
though these recommendations are mainly based on
retrospective cohort studies, it highlights the need for re-
search with stronger designs like RCTs to avoid con-
founding factors and confusion with cause and efect
variables. Moreover, the majority of studies have been
published in the last decade, which reflects the growing
interest for MDTs and interdisciplinary management of
DFUs.
This review has limitations that need to be considered
when interpreting the results. The available data is
largely derived from retrospective cohorts and pre and
post cohorts. Therefore, there is a limited ability to de-
termine true association between interventions and out-
comes. Observational studies are also not the preferred
design for meta-analysis. The review was also limited by
unavailable data or data that precluded us from pooling
the efect size even after multiple outreaches to authors.
One important concern regarding the high risk of bias
of the included studies arose mainly due to insuficiency
of reporting within the studies, making many criteria un-
clear. None of the included studies declared whether the
researchers had played a role in the delivery of care in
the MDT. Because we looked at the specific role of the
podiatrist, podiatrist researchers could introduce a bias
in favour of the intervention. Another concern is the
heterogeneity of populations and confounding factors.
Authors also agree that studies included in the meta-
analysis are heterogeneous in terms of methodology.
This is explained by nonblinded studies with no control
groups and the dificulties in addressing biases and con-
founders in retrospective studies. In addition, we pooled
unadjusted association measure data from observational
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studies. Although we made every atempt to address het-
erogeneity by conducting subgroup analyses, it made no
diference because of the smal number of studies
included.
There is a need to seek further evidence concerning
the efect of interventions for patients with diabetes and
to determine the role of podiatrists in MDTs related to
guideline recommendations [16,19,24,73]. Moreover,
more studies with stronger designs and methods are
needed to determine the efects of interventions on
DFUs and LEAs, with a special concern about risk strati-
fication in their population to avoid confounding fac-
tors. The research process should begin with beter
published studies. Future MDTs could also benefit from
addressing timing and care trajectories with stronger de-
scriptions of their specific interventions. It would also be
interesting to look at the impact between diferent popu-
lations (low risk versus high risk) and of other team
members’interventions.
Conclusion
This systematic review of interventions concerning out-
comes of LEAs in individuals with diabetes concludes
that there is insuficient evidence that MDTs with podia-
try management can reduce the risk of LEAs. Even with
a favourable outcome of the intervention, the lack of
high-quality studies included and considerable hetero-
geneity nuanced the results concerning relative risk re-
duction for total and major LEAs. This systematic
review’s conclusion folows the same direction as previ-
ous literature concerning the management of at-risk dia-
betic foot in MDTs, and supports previous conclusions
about the problem of heterogeneity concerning MDT
specialists that manage at-risk diabetic foot and the lack
of intervention description (nature, intensity, duration,
time of exposure, etc.).
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